ArticleCancer research and treatment2010

Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea.

Jae-Lyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.